Delta 9 Cannabis Inc (CVE:NINE) Director John William (John) Arbuthnot Iv Sells 1,750,000 Shares of Stock

Delta 9 Cannabis Inc (CVE:NINEGet Free Report) Director John William (John) Arbuthnot Iv sold 1,750,000 shares of the company’s stock in a transaction on Wednesday, May 22nd. The stock was sold at an average price of C$0.02, for a total value of C$35,000.00.

John William (John) Arbuthnot Iv also recently made the following trade(s):

  • On Thursday, April 18th, John William (John) Arbuthnot Iv bought 250,000 shares of Delta 9 Cannabis stock. The shares were acquired at an average price of C$0.03 per share, with a total value of C$6,250.00.

Delta 9 Cannabis Price Performance

CVE NINE traded up C$0.03 on Friday, hitting C$1.03. 68,728 shares of the company’s stock were exchanged, compared to its average volume of 117,300. The stock has a 50-day moving average of C$1.03 and a 200-day moving average of C$1.03. The company has a current ratio of 4.44, a quick ratio of 2.04 and a debt-to-equity ratio of 33.00. Delta 9 Cannabis Inc has a 52 week low of C$0.92 and a 52 week high of C$2.35. The stock has a market cap of C$89.36 million and a price-to-earnings ratio of 19.07.

About Delta 9 Cannabis

(Get Free Report)

Delta 9 Cannabis Inc operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc, engages in the production of medical marijuana. It primarily provides cannabis strains, as well as start-up materials and support services, including genetics (plants), grow pods, and consulting services to new and existing licensed producers.

Recommended Stories

Receive News & Ratings for Delta 9 Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delta 9 Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.